Affinium Pharmaceuticals
About:
Affinium Pharmaceuticals is a specialty pharmaceutical company, focused on the development of novel anti-infective medicines.
Website: http://www.afnm.com
Twitter/X: PINTSD
Top Investors: SV Health Investors, Forward Ventures, Oxford Bioscience Partners, Genesys Capital, The Ontario Capital Growth
Description:
Affinium Pharmaceuticals is a specialty pharmaceutical company focused on the development of novel anti-infective medicines. The Affinium FASII antibacterial programs constitute a new antibiotic franchise with the potential for multiple products targeting the FASII pathway. These programs include a broad base of long-term intellectual property: issued and pending composition of matter patents on potent orally available small molecule inhibitors for a new class of antibiotics with a unique mechanism of action, targeting an underexploited pathway.
$81.8M
$10M to $50M
Austin, Texas, United States
2000-01-01
oroberts(AT)afnm.com
Owen Roberts
11-50
2013-09-11
Private
© 2025 bioDAO.ai